Nutralife Biosciences Probability of Future Pink Sheet Price Finishing Over 1.0E-4
Nutralife Biosciences' future price is the expected price of Nutralife Biosciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Nutralife Biosciences performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Please specify Nutralife Biosciences' target price for which you would like Nutralife Biosciences odds to be computed.
Nutralife |
Nutralife Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Nutralife Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Nutralife Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Nutralife Biosciences is not yet fully synchronised with the market data | |
| Nutralife Biosciences has some characteristics of a very speculative penny stock | |
| Nutralife Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Nutralife Biosciences currently holds 10 K in liabilities. Nutralife Biosciences has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nutralife Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Nutralife Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nutralife Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nutralife to invest in growth at high rates of return. When we think about Nutralife Biosciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 626.62 K. Net Loss for the year was (5.83 M) with profit before overhead, payroll, taxes, and interest of 83.59 K. | |
| Nutralife Biosciences currently holds about 51.8 K in cash with (487.39 K) of positive cash flow from operations. | |
| Roughly 46.0% of the company outstanding shares are owned by corporate insiders |
Nutralife Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Nutralife Pink Sheet often depends not only on the future outlook of the current and potential Nutralife Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nutralife Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 146.3 M | |
| Cash And Short Term Investments | 135.8 K |
Nutralife Biosciences Technical Analysis
Nutralife Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Nutralife Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Nutralife Biosciences. In general, you should focus on analyzing Nutralife Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Nutralife Biosciences Predictive Forecast Models
Nutralife Biosciences' time-series forecasting models is one of many Nutralife Biosciences' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Nutralife Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Nutralife Biosciences
Checking the ongoing alerts about Nutralife Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Nutralife Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Nutralife Biosciences is not yet fully synchronised with the market data | |
| Nutralife Biosciences has some characteristics of a very speculative penny stock | |
| Nutralife Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Nutralife Biosciences currently holds 10 K in liabilities. Nutralife Biosciences has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nutralife Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Nutralife Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nutralife Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nutralife to invest in growth at high rates of return. When we think about Nutralife Biosciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 626.62 K. Net Loss for the year was (5.83 M) with profit before overhead, payroll, taxes, and interest of 83.59 K. | |
| Nutralife Biosciences currently holds about 51.8 K in cash with (487.39 K) of positive cash flow from operations. | |
| Roughly 46.0% of the company outstanding shares are owned by corporate insiders |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Nutralife Pink Sheet
If you are still planning to invest in Nutralife Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nutralife Biosciences' history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |